Literature DB >> 17442991

High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.

Riitta A Niinimäki1, Arja H Harila-Saari, Airi E Jartti, Raija M Seuri, Pekka V Riikonen, Eija L Pääkkö, Merja I Möttönen, Marjatta Lanning.   

Abstract

PURPOSE: The aim of the study was to determine the incidence of and clinical risk factors for radiographic osteonecrosis (ON) in children treated for acute lymphoblastic leukemia (ALL) using the Nordic ALL protocols. PATIENTS AND METHODS: Ninety-seven consecutive patients with childhood ALL were studied prospectively by magnetic resonance imaging (MRI) of the lower extremities at the end of the treatment.
RESULTS: Twenty-three (24%) of the 97 patients had ON. Seven of the patients (30%) were symptomatic, and three patients (13%) required surgical interventions. Multiple logistic regression analysis showed that high body mass index (BMI; P = .04), female sex (P = .01), older age at diagnosis (P < .001), and higher cumulative dexamethasone dose (P = .03) were independent risk factors for radiographic ON. The cumulative prednisone dose did not differ significantly between the patients with and without ON. The incidence of radiographic ON decreased significantly, from 36% to 7%, when the duration of dexamethasone exposure during the delayed-intensification phase was shortened from 3 to 4 weeks to 2 weeks with a taper (P = .001).
CONCLUSION: ON as determined by MRI was found to be a common complication in children and adolescents after treatment with the Nordic ALL protocols. Revision of the ALL protocols by shortening the single exposure to dexamethasone has diminished the risk for ON remarkably. High BMI was identified as a new significant risk factor for ON.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442991     DOI: 10.1200/JCO.2006.06.2539

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  34 in total

Review 1.  Osteonecrosis in children after therapy for malignancy.

Authors:  Sue C Kaste; Evguenia J Karimova; Michael D Neel
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

2.  Milestones in the curability of pediatric cancers.

Authors:  Melissa M Hudson; Michael P Link; Joseph V Simone
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

Review 3.  Osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Marina Kunstreich; Sebastian Kummer; Hans-Juergen Laws; Arndt Borkhardt; Michaela Kuhlen
Journal:  Haematologica       Date:  2016-10-14       Impact factor: 9.941

Review 4.  Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge.

Authors:  Michaela Kuhlen; Marina Kunstreich; Kathinka Krull; Roland Meisel; Arndt Borkhardt
Journal:  Blood Adv       Date:  2017-06-13

5.  Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and Denmark.

Authors:  Riitta Niinimäki; Lene Mølgaard Hansen; Tuukka Niinimäki; Jørgen H Olsen; Tytti Pokka; Risto Sankila; Kim Vettenranta; Henrik Hasle; Arja Harila-Saari
Journal:  J Adolesc Young Adult Oncol       Date:  2013-12-01       Impact factor: 2.223

6.  Relative volume measured with magnetic resonance imaging is an articular collapse predictor in hematological pediatric patients with femoral head osteonecrosis.

Authors:  Davide Ippolito; Alessandro Masetto; Cammillo Talei Franzesi; Pietro A Bonaffini; Alessandra Casiraghi; Sandro Sironi
Journal:  World J Radiol       Date:  2016-08-28

7.  Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Authors:  Vincent Gagné; Anne Aubry-Morin; Maria Plesa; Rachid Abaji; Kateryna Petrykey; Pascal St-Onge; Patrick Beaulieu; Caroline Laverdière; Nathalie Alos; Jean-Marie Leclerc; Stephen E Sallan; Donna Neuberg; Jeffery L Kutok; Lewis B Silverman; Daniel Sinnett; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2019-11-05       Impact factor: 2.533

8.  An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.

Authors:  Justine M Kahn; Peter D Cole; Traci M Blonquist; Kristen Stevenson; Zhezhen Jin; Sergio Barrera; Randy Davila; Emily Roberts; Donna S Neuberg; Uma H Athale; Luis A Clavell; Caroline Laverdiere; Jean-Marie Leclerc; Bruno Michon; Marshall A Schorin; Jennifer J G Welch; Stephen E Sallan; Lewis B Silverman; Kara M Kelly
Journal:  Pediatr Blood Cancer       Date:  2017-11-01       Impact factor: 3.167

9.  Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.

Authors:  Emily R Finch; Laura J Janke; Colton A Smith; Seth E Karol; Deqing Pei; Cheng Cheng; Sue C Kaste; Hiroto Inaba; Ching-Hon Pui; Joshua Wolf; Mary V Relling
Journal:  Pediatr Blood Cancer       Date:  2019-02-13       Impact factor: 3.167

10.  Osteonecrosis of the femoral head in childhood malignancy.

Authors:  Stephanie W Mayer; Braden K Mayer; J Mack Aldridge; James R Urbaniak; Robert D Fitch; Robert K Lark
Journal:  J Child Orthop       Date:  2012-12-25       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.